IP Library Granted Patent US 7,399,307
Granted Patent B2
US 7,399,307 · App. 10/438,266 · Granted Jul 15, 2008

Apparatus and method for removing occlusive material within blood vessels

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,399,307
App. No.
10/438,266
Granted
Jul 15, 2008
Kind
B2
Abstract

An apparatus for treating an occlusive region of a blood vessel includes a catheter including a first lumen extending from an end port to a first side port, and a second lumen extending from a proximal end of the catheter to a second side port. A balloon is mounted on the catheter between the first and second side ports. During use, a guidewire is placed into an occlusive region, and the guidewire is backloaded through the first and second lumens. The catheter is advanced over the guidewire, and the balloon is expanded to isolate the occlusive region. The guidewire is removed, and an agitator is advanced through the second lumen. After the agitator is agitated to dislodge occlusive material from the occlusive region, the agitator is removed, and the loose occlusive material is aspirated via the second side port.

Claims (35)

1. A method for treating an occlusive region of a patient's vasculature using a tubular member comprising proximal and distal ends, and a distal portion comprising a first lumen therein, the first lumen comprising an end port at or adjacent to the distal end and a first side port located proximally to the end port, the tubular member further comprising a second lumen extending from the proximal end to a second side port located proximally to the first side port, and an expandable member between the first and second side ports, the method comprising:

placing a guidewire through a patient's vasculature to an occlusive region to be treated;

backloading the guidewire through the first lumen, around the expandable member, and through the second lumen;

advancing the distal portion of the tubular member over the guidewire to the occlusive region;

expanding the expandable member on the tubular member to at least partially isolate the occlusive region;

advancing a treatment element into the occlusive region in cooperation with the tubular member; and

treating the occlusive region.

2. The method of claim 1 , wherein the step of advancing a treatment element comprises:

removing the guidewire from the second lumen; and

advancing the treatment element through the second lumen to the occlusive region.

3. The method of claim 2 , wherein the treatment element causes at least a portion of the distal portion of the tubular member to assume a nonlinear configuration.

4. The method of claim 3 , wherein the treating step comprises agitating the treatment element to disrupt or dislodge occlusive material from the occlusive region.

5. The method of claim 1 , wherein the treating step comprises introducing a therapeutic or diagnostic agent into the occlusive region.

6. The method of claim 5 , wherein the therapeutic or diagnostic agent comprises a thrombolytic agent.

7. The method of claim 3 , wherein the treating step further comprises creating a vacuum at the second side port to aspirate occlusive material from the occlusive region.

8. The method of claim 7 , wherein the treatment element is removed from the second lumen before creating a vacuum.

9. The method of claim 1 , wherein the expandable member comprises a distal expandable member, and wherein the method further comprises:

expanding a proximal expandable member to isolate at least a portion of the occlusive region.

10. The method of claim 9 , wherein the proximal expandable member is disposed on the tubular member at a location proximal to the second side port.

11. The method of claim 9 , wherein the proximal expandable member is carried on a distal portion of an elongate member advanced to the occlusive region.

12. The method of claim 11 , wherein the elongate member comprises a balloon catheter that is advanced over the tubular member to the occlusive region.

13. The method of claim 1 , further comprising removing the guidewire from the distal portion of the elongate member before expanding the expandable member.

14. A method for treating an occlusive region of a patient's vasculature using a tubular member comprising proximal and distal ends, a lumen therein extending from the proximal end to a side port in the distal portion, an expandable member on the distal portion between the side port and the distal end, and a loop on the distal end, the method comprising:

placing a guidewire through a patient's vasculature to an occlusive region to be treated;

backloading the guidewire through the loop, around the expandable member, and through the lumen;

advancing the distal portion of the tubular member over the guidewire to the occlusive region;

expanding the expandable member on the tubular member to at least partially isolate the occlusive region;

removing the guidewire from the lumen;

advancing a treatment element through the lumen into the distal portion; and

treating the occlusive region using the treatment element.

15. The method of claim 14 , wherein the treatment element causes at least a portion of the distal portion of the tubular member to assume a nonlinear configuration.

16. The method of claim 14 , wherein the treating step comprises agitating the treatment element to disrupt or dislodge occlusive material from the occlusive region.

17. The method of claim 16 , wherein the treating step further comprises introducing a thrombolytic agent into the occlusive region.

18. The method of claim 16 , wherein the treating step further comprises creating a vacuum at the second side port to aspirate occlusive material from the occlusive region.

19. The method of claim 14 , wherein the guidewire is removed from the lumen before expanding the expandable member.

Assignments (7)
CHANGE OF NAME Recorded Jan 9, 2013
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029595/0101 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2010
From: SHERWOOD MEDICAL COMPANY I
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 024651/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2010
From: VALLEYLAB HOLDING CORPORATION
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 024651/0256 →
ASSIGNMENT OF FORTY NINE PERCENT (49%) OF ASSIGNOR'S ENTIRE RIGHT, TITLE, AND INTEREST Recorded Jul 8, 2010
From: BACCHUS VASCULAR, LLC
To: VALLEYLAB HOLDING CORPORATION
Reel/Frame 024651/0309 →
ASSIGNMENT OF FIFTY ONE PERCENT (51%) OF ASSIGNOR'S ENTIRE RIGHT, TITLE, INTEREST, AND THE GOODWILL Recorded Jul 8, 2010
From: BACCHUS VASCULAR, LLC
To: SHERWOOD MEDICAL COMPANY I
Reel/Frame 024651/0280 →
MERGER Recorded Jul 7, 2010
From: BACCHUS VASCULAR, INC.
To: BACCHUS VASCULAR, LLC
Reel/Frame 024640/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2003
From: EVANS, MICHAEL A.; DEMARAIS, DENISE; KHAIRKHAHAN, ALEXANDER; DECICCO, DINO
To: BACCHUS VASCULAR INC.
Reel/Frame 014441/0328 →